Feasibility of combining temsirolimus to vincristine, dactinomycin, cyclophosphamide, and vincristine and irinotecan chemotherapy for children with intermediate‐risk rhabdomyosarcoma: A report from Children's Oncology Group Journal Article
| Authors: | Oberoi, S.; Qumseya, A.; Xue, W.; Harrison, D. J.; Rudzinski, E. R.; Wolden, S. L.; Dasgupta, R.; Venkatramani, R.; Gupta, A. A. |
| Article Title: | Feasibility of combining temsirolimus to vincristine, dactinomycin, cyclophosphamide, and vincristine and irinotecan chemotherapy for children with intermediate‐risk rhabdomyosarcoma: A report from Children's Oncology Group |
| Journal Title: | Pediatric Blood and Cancer |
| Volume: | 70 |
| Issue: | 9 |
| ISSN: | 1545-5009 |
| Publisher: | Wiley Periodicals, Inc |
| Date Published: | 2023-09-01 |
| Start Page: | e30436 |
| Language: | English |
| DOI: | 10.1002/pbc.30436 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| PUBMED: | 37243336 |
| PMCID: | PMC10676447 |
| DOI/URL: | |
| Notes: | Accession Number: 166734926 -- Entry Date: In Process -- Revision Date: 20230727 -- Publication Type: Article -- Journal Subset: Biomedical; Peer Reviewed; USA -- NLM UID: 101186624. -- Source: Cinahl |
